Ute Gesche Tallen
Department of Pediatric Oncology/Haematology
Charité-Universitätsmedizin Berlin
13353 Berlin
Germany
Name/email consistency: high
- The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells. Tallen, G., Farhangi, S., Tamannai, M., Holtkamp, N., Mangoldt, D., Shah, S., Suzuki, K., Truss, M., Henze, G., Riabowol, K., von Deimling, A. Oncol. Res. (2009)
- Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death. Tallen, U.G., Truss, M., Kunitz, F., Wellmann, S., Unryn, B., Sinn, B., Lass, U., Krabbe, S., Holtkamp, N., Hagemeier, C., Wurm, R., Henze, G., Riabowol, K.T., von Deimling, A. J. Neurooncol. (2008)
- No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma. Tallen, G., Kaiser, I., Krabbe, S., Lass, U., Hartmann, C., Henze, G., Riabowol, K., von Deimling, A. Int. J. Cancer (2004)
- Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells. Tallen, G., Riabowol, K., Wolff, J.E. Anticancer Res. (2003)